Ron Johnson Hearings Volume 7 - Cheap Therapeutics were Blocked
Immune to the System is a comedic political talk show hosted by comedy couple Lila Hart and Eric Abbenante. Each episode they will provide the audience information on how to become Immune to the system that tries to control us. The machine does not control the cogs within, the cogs control the machine, we just have to realize our power!
Ron Johnson Hearings: Ron Johnson Senator from Wisconsin held hearings on vaccine injured that were blockbuster, groundbreaking, and lead the news. His follow up was just as significant: "Covid-19 : A Second Opinion" featured doctors and other experts in the fields of medicine , virology and other related fields including doctors Robert Malone, Peter McCollough, Paul Marik, Aaron Kheriarty, and much more. These hearings were featured over a series of episodes of Immune to the System.
Volume 7: Cheap Therapeutics were Blocked
-
5:11
Asher Press
10 months agoNIH Discourages Off-Patent Drugs While Collecting Royalties on New Products! - Rep. John Moolenaar
212 -
7:38
Asher Press
9 months agoJoe Rogan & Alex Berenson on the Real Cost of Pharmaceutical Incentives
397 -
7:38
The Joe Rogan Experience Podcast
9 months agoJournalist Alex Berenson on the Real Cost of Pharmaceutical Incentives
4.78K -
10:35
Kitz's Corner
9 months agoHow John Rockefeller SQUASHED Natural Remedies to Make Big Pharma!
38 -
41:41
MJDOC
1 year agoSen Ron Johnson discusses COVID and Big Pharma on FLCCC
1644 -
3:59
@7THSN1PER
10 months agoBig💊Pharma💉In Full🔥Panic😨Senator💥Johnson👀Exposes💥Elite Group🤬Behind Covid💉Hysteria💥🔥😎
16 -
9:22
The Rubin Report
1 year agoThe High Cost of Breaking Clinical Trial Rules (Pt. 1)| Dr. Robert Malone | POLITICS | Rubin Report
5.57K21 -
18:10
SF Web Agency
1 year agoSenator Ron Johnson's Public Hearing - Horrific Effects Of The COVID 19 "vaccinations"
5731 -
6:00
One America News Network
3 years agoHealth Policy Expert Reveals Flaws of Drug Pricing Bill
9416 -
12:37
Bannons War Room
2 years agoDr. Toby Rogers: The FDA Wants To Eliminate ‘Clinical Trials’ For Pharmaceuticals Companies
19.3K63